Taiwan Land Development Corp (TLDC, 台灣土地開發) has partnered with Ivy Life Sciences Co (常春藤生命科學) to develp an immunotherapy business in Kinmen, with a view to attracting customers from China.
The Taipei-based developer inked a memorandum of understanding with Ivy Life to set up a cell biology laboratory on the outlying island, which could start operating in 2021 after gaining approval from heath authorities.
The joint venture, valued at NT$500 million (US$15.89 million), came after the government in September last year gave its go-ahead to special rules governing immunotherapy, a type of cancer treatment that boosts the body’s natural defenses to fight cancer.
Photo: Chen Yung-chi, Taipei Times
The Ministry of Health and Welfare on May 3 issued the first cell treatment license to Tri-Service General Hospital, allowing it to use cell-based immunotherapy with cytokine induced-killer cells (CIK) on patients, with help from Ivy Life, the only government-certified laboratory with the domain knowhow.
The deregulation makes Taiwan the first nation in Asia to tap into a business linked to cell treatment that could generate NT$10 billion in the next six months alone, Ivy Life general manager Terry Chang (張泰銘) said.
The treatment targets mainly wealthy patients with advanced lung, liver or blood cancer, as well as degenerative arthritis, cartilage defects and other illnesses, Chang said.
TLDC runs a shopping mall, Wind Lion Plaza (風獅城), in Kinmen that has become a popular attraction among Chinese tourists, TLDC chairman Chiu Fu-sheng (邱復生) said.
Kinmen is only 40 minutes from Xiamen, China, by boat.
Rich Chinese patients might desire the treatment, which can help strengthen the immune system without negative side effects, but is not yet available in China, Chang said.
A treatment course would need six to eight shots at a cost of NT$300,000 each, he said.
The laboratory would be set up in a residential complex, another part of a build-operate-transfer venture with the county government like the shopping mall, TLDC president Vicki Chiu (邱于芸) said.
Kinmen is ideal for developing tourism and preventive medicine given its scenic views and a fast-growing number of senior citizens, Viki Chiu said, as the offshore county has lost its young population to Taiwan proper.
The cell treatment could bring more tourists to Kinmen and invigorate its economy as a whole, Chiu said.
SECOND-RATE: Models distilled from US products do not perform the same as the original and undo measures that ensure the systems are neutral, the US’ cable said The US Department of State has ordered a global push to bring attention to what it said are widespread efforts by Chinese companies, including artificial intelligence (AI) start-up DeepSeek (深度求索), to steal intellectual property from US AI labs, according to a diplomatic cable. The cable, dated Friday and sent to diplomatic and consular posts around the world, instructs diplomatic staff to speak to their foreign counterparts about “concerns over adversaries’ extraction and distillation of US AI models.” Distillation is the process of training smaller AI models using output from larger, more expensive ones to lower the costs of training a powerful new
Micron Technology Inc is a driving force pushing the US Congress to pass legislation that would put new export restrictions on equipment its Chinese competitors use to make their chips, according to people familiar with the matter. A US House of Representatives panel yesterday was to vote on the “MATCH Act,” a bill designed to close gaps in restrictions on chipmaking equipment. It would also pressure foreign companies that sell equipment to Chinese chipmaking facilities to align with export curbs on US companies like Lam Research Corp and Applied Materials Inc. The bill targets facilities operated by China’s ChangXin Memory Technologies Inc
Singapore-based ride-hailing and delivery giant Grab Holdings’ planned acquisition of Foodpanda’s Taiwan operations has yet to enter the formal review stage, as regulators await supplementary documents, the Fair Trade Commission (FTC) said yesterday. Acting FTC Chairman Chen Chih-min (陳志民) told the legislature’s Economics Committee that although Grab submitted its application on March 27, the case has not been officially accepted because required materials remain incomplete. Once the filing is finalized, the FTC would launch a formal probe into the deal, focusing on issues such as cross-shareholding and potential restrictions on market competition, Chen told lawmakers. Grab last month announced that it would acquire
The artificial intelligence (AI) boom has triggered a seismic reshuffling of global equity markets, with Taiwan and South Korea muscling past European nations one by one. With its stock market now valued at nearly US$4.3 trillion, Taiwan surpassed the UK, Europe’s biggest market, earlier this month, data compiled by Bloomberg showed. South Korea is about US$140 billion away from doing the same. The tech-heavy Asian markets have shot past Germany and France in the past seven months. The shift is largely down to massive gains in shares of three companies that provide essential hardware for AI: Taiwan Semiconductor Manufacturing Co (TSMC, 台積電),
RSS